Spire Healthcare Group PLC (LON:SPI) had its price target reduced by investment analysts at J P Morgan Chase & Co from GBX 376 ($4.86) to GBX 339 ($4.38) in a report issued on Friday, MarketBeat reports. The brokerage currently has a “neutral” rating on the stock. J P Morgan Chase & Co’s target price indicates a potential upside of 30.28% from the company’s current price.

A number of other research analysts have also weighed in on SPI. Numis Securities Ltd reissued an “add” rating and issued a GBX 350 ($4.52) price objective on shares of Spire Healthcare Group PLC in a report on Thursday. Liberum Capital reissued a “buy” rating and issued a GBX 400 ($5.17) price objective on shares of Spire Healthcare Group PLC in a report on Tuesday, June 13th. Jefferies Group LLC increased their price objective on Spire Healthcare Group PLC from GBX 305 ($3.94) to GBX 350 ($4.52) and gave the company a “hold” rating in a report on Thursday, June 1st. Berenberg Bank increased their price objective on Spire Healthcare Group PLC from GBX 360 ($4.65) to GBX 390 ($5.04) and gave the company a “buy” rating in a report on Wednesday, June 21st. Finally, Credit Suisse Group reissued an “underperform” rating on shares of Spire Healthcare Group PLC in a report on Friday, July 21st. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and one has given a buy rating to the company’s stock. Spire Healthcare Group PLC presently has an average rating of “Hold” and an average price target of GBX 347 ($4.48).

Shares of Spire Healthcare Group PLC (LON SPI) traded up 3.17% on Friday, reaching GBX 260.20. The company’s stock had a trading volume of 3,350,487 shares. The stock’s market cap is GBX 1.04 billion. The firm has a 50 day moving average price of GBX 327.79 and a 200-day moving average price of GBX 332.90. Spire Healthcare Group PLC has a 12-month low of GBX 228.48 and a 12-month high of GBX 411.00.

Spire Healthcare Group PLC (LON:SPI) last announced its quarterly earnings data on Thursday, September 14th. The company reported GBX 8.70 ($0.11) earnings per share for the quarter, beating analysts’ consensus estimates of GBX 8.60 ($0.11) by GBX 0.10 ($0.00). The business had revenue of £481 million for the quarter. Spire Healthcare Group PLC had a return on equity of 3.47% and a net margin of 3.92%. Equities research analysts expect that Spire Healthcare Group PLC will post $18.48 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: This report was first published by American Banking News and is the property of of American Banking News. If you are accessing this report on another site, it was illegally copied and reposted in violation of United States & international copyright & trademark legislation. The correct version of this report can be read at https://www.americanbankingnews.com/2017/09/16/spire-healthcare-group-plc-spi-price-target-lowered-to-gbx-339-at-j-p-morgan-chase-co.html.

About Spire Healthcare Group PLC

Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.

Analyst Recommendations for Spire Healthcare Group PLC (LON:SPI)

Receive News & Ratings for Spire Healthcare Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.